The cannabis rumor mill is buzzing: President Donald Trump is “looking at” moving marijuana from Schedule I, the same federal category as heroin, to the less restrictive Schedule III. Depending on who you ask, it’s a serious policy shift, a calculated political move, or just more Washington smoke and mirrors.
So… is it real?
The Fundraiser That Sparked It
Reports from the Wall Street Journal say the conversation began at an August fundraiser at Trump’s Bedminster golf club, where seats went for $1 million each. According to multiple attendees, Trump told the room that he was “interested” in making the change and flagged it to staff on the spot. Trulieve CEO Kim Rivers was there and urged him to push the reform and expand medical cannabis research.
Also in the room: Pfizer’s CEO, cryptocurrency executives, and some of Trump’s top political advisers. Sources told the WSJ this was a targeted pitch from cannabis companies after months of seeing the process stall at federal agencies.
What Other Outlets Report
CNN confirmed the dinner conversation and added that Chief of Staff Susie Wiles now has agency reports on her desk outlining the pros and cons. Political aides reportedly see cannabis reform as a broadly popular “80-20” issue, while some policy advisers warn it could conflict with Trump’s tough-on-crime brand.
Earlier this month, Marijuana Moment had reported that Scotts Miracle-Gro CEO James Hagedorn says Trump has told him “multiple times” since January that he will follow through.
The Money and the Pushback
Cannabis companies and allied PACs have invested millions into Trump’s political network. American Rights and Reform PAC gave $1 million to a Trump PAC and paid $300,000 to MAGA adviser Alex Bruesewitz to promote the cause. Lobbyists Brian Ballard and Nick Iarossi have also been active.
But not …
Read More
Author: Javier Hasse / High Times
